🚨Overtreatment of #ProstateCancer  Among Men With Limited Longevity🚨

👉Just out in @JAMAInternalMed 

🧑🧔‍♂️👴>240k pts w/ localized PCa from the VA (2000-2019)

📈Increased use of surveillance for low-risk tumors😃
BUT ALSO
📈Increased definitive treatment (surgery or XRT) for patients w/ limited (<5y) life expectancy😣

🎙️To quote the discussion
"Even a higher-risk tumor would pose little threat to a patient with limited life expectancy."

🔗👏@TimDaskivich @johnleppert 

@CedarsSinai @CedarsSinaiMed @UroResidentsCS @CSCancerCenter @StanfordUrology
#ProstateCancer